VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With Diabetic Macular Edema

Thursday, February 18, 2010 Research News
Email Print This Page Comment
Font : A-A+

- Statistically significant improvement in vision achieved over 24 weeks

Contact Information:

Regeneron Pharmaceuticals, Inc.

Peter Dworkin

Laura Lindsay

Investor Relations

Media Relations

914.345.7640

914.345.7800

peter.dworkin@regeneron.com

laura.lindsay@regeneron.com

Bayer HealthCare

Anna Koch,

+49 30 468-15942

anna.koch@bayerhealthcare.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook